BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3894585)

  • 1. Current status of chemotherapy for advanced pancreatic and gastric cancer.
    O'Connell MJ
    J Clin Oncol; 1985 Jul; 3(7):1032-9. PubMed ID: 3894585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of chemotherapy in the management of gastric and pancreatic carcinomas.
    Schein PS
    Semin Oncol; 1985 Dec; 12(4 Suppl 6):49-60. PubMed ID: 3936182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of chemotherapy in the treatment of advanced gastric and pancreas cancer.
    Kelsen D
    Semin Oncol; 1994 Aug; 21(4 Suppl 7):58-66. PubMed ID: 8091242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant and neoadjuvant therapy for gastric cancer.
    Kelsen DP
    Semin Oncol; 1996 Jun; 23(3):379-89. PubMed ID: 8658222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antineoplastic chemotherapy in advanced gastric cancer].
    Tanneberger S
    Arch Geschwulstforsch; 1982; 52(5):385-95. PubMed ID: 6756336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin.
    Cullinan SA; Moertel CG; Fleming TR; Rubin JR; Krook JE; Everson LK; Windschitl HE; Twito DI; Marschke RF; Foley JF
    JAMA; 1985 Apr; 253(14):2061-7. PubMed ID: 2579257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update in cancer chemotherapy: gastrointestinal cancer, cancer of the stomach and carcinoid tumors.
    Wright JC
    J Natl Med Assoc; 1986 Jul; 78(7):623-32. PubMed ID: 3528508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent advances in chemotherapy for advanced gastric cancer: from the standpoint of survival advantages].
    Ohtsu A; Yoshida S; Miyata Y; Shimada Y
    Gan To Kagaku Ryoho; 1995 Mar; 22(4):444-50. PubMed ID: 7887636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of clinical response to first-line chemotherapy on gastric cancer patients treated with second-line and third-line chemotherapy.
    Kodera Y; Ito Y; Ohashi N; Nakayama G; Koike M; Fujiwara M; Nakao A
    Hepatogastroenterology; 2011; 58(107-108):1041-5. PubMed ID: 21830439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical development of S-1 (TS-1) for advanced gastric cancer].
    Wasaburo K; Tanabe S; Higuchi K; Sasaki T; Nakayama N; Mihara S; Nakatani K; Nishimura K; Shimoda T; Azuma M; Katada C; Hanaoka N; Naruke A; Ryu T; Ishido K; Saigenji K
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():57-63. PubMed ID: 16897973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of systemic therapy for advanced pancreatic cancer.
    El-Rayes BF; Philip PA
    Clin Adv Hematol Oncol; 2003 Jul; 1(7):430-4. PubMed ID: 16258429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy of gastric and pancreatic carcinoma: a controlled evaluation of combinations of 5-fluorouracil with nitrosoureas and "lactones".
    Moertel CG; Engstrom P; Lavin PT; Gelber RD; Carbone PP
    Surgery; 1979 May; 85(5):509-13. PubMed ID: 155322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective evaluation of sequential outpatient chemotherapy for advanced gastric cancer.
    Satoh S; Kawashima K; Matsumoto S; Hasegawa S; Okabe H; Nomura A; Yoshibayashi H; Watanabe G; Nagayama S; Fukushima M; Sakai Y
    Chemotherapy; 2007; 53(3):226-32. PubMed ID: 17356271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adjuvant chemotherapy in cancers of the stomach, pancreas and intestine].
    Martin F
    Bull Cancer; 1984; 71(4):374-6. PubMed ID: 6498350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy for resectable and advanced pancreatic cancer.
    Berlin JD; Rothenberg M
    Oncology (Williston Park); 2001 Oct; 15(10):1241-9, 1254; discussion 1254-64. PubMed ID: 11702956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemotherapy for advanced gastric cancer--our possibilities in 2007].
    Dank M; Torgyík L; Szentmártoni G
    Magy Onkol; 2007; 51(3):209-17. PubMed ID: 17922060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there an optimal chemotherapy regimen for the treatment of advanced gastric cancer that will provide a platform for the introduction of new biological agents?
    Pozzo C; Barone C
    Oncologist; 2008 Jul; 13(7):794-806. PubMed ID: 18614586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New chemotherapeutic advances in pancreatic, colorectal, and gastric cancers.
    Diaz-Rubio E
    Oncologist; 2004; 9(3):282-94. PubMed ID: 15169983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of chemotherapy in metastatic pancreatic cancer.
    Wils JA
    Anticancer Res; 1989; 9(4):1027-31. PubMed ID: 2683988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cetuximab: still an option in the treatment of pancreatic cancer?
    Faloppi L; Andrikou K; Cascinu S
    Expert Opin Biol Ther; 2013 May; 13(5):791-801. PubMed ID: 23560505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.